LEXINGTON, Mass.--(BUSINESS WIRE)--BioScale, Inc. a life science company that develops ultrasensitive protein analysis technology, presented findings of recently completed research studies on phospho-protein analysis of the in vitro and in vivo kinase expression in the MAP kinase pathway at the 22nd Biennial European Association for Cancer Research (EACR) Congress, held in Barcelona, Spain, July 7-10, 2012.
